<![CDATA[
<p>**** 올릭스 (226950) <br>올릭스 RNA 관련 미국특허 취득 </p><p> </p><p>기타 경영사항(특허권 취득)(자율공시) <br>1. 특허명칭 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR POTENTIATING GENE SILENCING <br>2. 특허 주요내용 본 특허는 유전자 발현을 억제하는 방법에 관한 것으로, 구체적으로 cp-asiRNA 또는 lasiRNA와, 실니디핀, 니카르디핀, 니페디핀 또는 암로디핀과 같은 L-유형 칼슘 채널 차단제를 함께 투여하는 유전자 발현을 억제하는 방법을 청구하고 있습니다. <br>3. 특허권자 올릭스(주) <br>4. 특허취득일자 2021-05-17 <br>5. 특허 활용계획 당사는 본 특허에 따른 방법인 L-유형 칼슘 채널 차단제를 siRNA와 함께 투여하는 경우 siRNA의 세포 내 전달이 향상되는 것을 확인하였고, 이를 통해 당사의 siRNA 치료 효능 개선의 가능성을 확인하였으며, 당사는 본 특허에 따른 방법을 이용하여 당사의 플랫폼 기술을 개선하고 나아가, 이를 당사의 여러 파이프라인 치료제 개발에 본 특허를 활용할 계획입니다. <br>6. 확인일자 2021-05-18 <br>7. 기타 투자판단에 참고할 사항 - 상기 특허는 미국특허청(USPTO)에 등록된 특허입니다. <br>- 상기 특허의 출원번호는 16/313,754 입니다. <br>- 상기 특허 취득을 위한 수수료는 2021년 05월 17일 납부 완료하였습니다</p><p><br><a href="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119" target="_blank" class="ke-link">http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119</a></p><div class="figure-open" contenteditable="false" data-ke-type="opengraph" data-ke-align="alignCenter" data-og-type="website" data-og-title="올릭스/기타경영사항(특허권취득)(자율공시)/2021.05.18" data-og-description="" data-og-host="dart.fss.or.kr" data-og-source-url="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119" data-og-url="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119"><a href="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119" target="_blank" data-source-url="http://dart.fss.or.kr/dsaf001/main.do?rcpNo=20210518900119"><div class="og-image" style="background-image:url(null)"></div><div class="og-text"><p class="og-title">올릭스/기타경영사항(특허권취득)(자율공시)/2021.05.18</p><p class="og-desc"></p><p class="og-host">dart.fss.or.kr</p></div></a></div><p> </p>
<!-- -->
]]>
